Context-Specific Efficacy of Apalutamide Therapy in Preclinical Models of <i>Pten</i>-Deficient Prostate Cancer.

In CNPC, the cancer cell proliferation rates tended to be lower in the combination-treated mice compared to monotherapy, although these failed to reach statistical significance ( Figure 6 C).

also in 6,035 other papers